8 Therefore, given the increasing burden of lean MASLD in some populations and the benefits of GLP-1RA in weight management, more clinical attention is warranted
In females, obesity is often associated with conditions such as polyendocrine metabolic ovarian syndrome (PMOS), formerly knows as PCOS, while in males, it can reduce testosterone levels and adversely affect sperm quality
If your surgical team is unfamiliar with GLP-1 therapy, PlexusDx can provide brief medical literature or contact information to help educate them about safe anesthesia protocols
Most people begin seeing consistent results by weeks 2-3
In a phase II trial, people with obesity taking high doses lost up to 24.2 percent of body weight over 48 weeks, eclipsing what is typically seen with single or dual agonists